Gregory P Bisson Selected Research

Cryptococcal Meningitis

1/2019	Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.
6/2015	AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.
4/2013	Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
10/2008	The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory P Bisson Research Topics

Disease

30	Tuberculosis (Tuberculoses) 01/2021 - 10/2008
6	Infections 10/2017 - 04/2011
5	Pulmonary Tuberculosis 10/2020 - 12/2013
5	Inflammation (Inflammations) 01/2020 - 10/2012
4	Immune Reconstitution Inflammatory Syndrome 10/2020 - 04/2015
4	HIV Infections (HIV Infection) 01/2020 - 10/2012
4	Cryptococcal Meningitis 01/2019 - 10/2008
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 05/2008
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 06/2014
2	Meningeal Tuberculosis (Tuberculous Meningitis) 03/2011 - 09/2010
1	Pneumonia (Pneumonitis) 01/2020
1	Lung Injury 01/2020
1	Chemical and Drug Induced Liver Injury 01/2020
1	Drug-Related Side Effects and Adverse Reactions 04/2019
1	Hepatitis 01/2018
1	Lymphadenopathy 10/2017
1	Coinfection 05/2017
1	Central Nervous System Infections (Central Nervous System Infection) 06/2015
1	Epilepsy (Aura) 06/2015
1	AIDS Dementia Complex 06/2015
1	Necrosis 04/2015
1	Latent Tuberculosis 10/2013
1	Lung Diseases (Lung Disease) 10/2013
1	Insulin Resistance 10/2012
1	Anemia 01/2011
1	Viremia 11/2005

Drug/Important Bio-Agent (IBA)

7	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021 - 09/2010
6	Pharmaceutical PreparationsIBA 01/2020 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2015
3	Pyrazinamide FDA LinkGeneric 03/2018 - 04/2011
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2016 - 12/2012
3	RNA (Ribonucleic Acid)IBA 12/2013 - 11/2005
2	InflammasomesIBA 01/2020 - 05/2018
2	AcidsIBA 01/2020 - 10/2013
2	liposomal amphotericin B FDA Link 01/2019 - 06/2015
2	Interleukin-6 (Interleukin 6)IBA 03/2016 - 04/2015
2	Tuberculin (PPD)IBA 10/2013 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2012 - 04/2011
1	lipoarabinomannan (LAM)IBA 01/2021
1	AntigensIBA 01/2021
1	Antitubercular AgentsIBA 01/2020
1	Ethambutol (Myambutol)FDA LinkGeneric 10/2019
1	efavirenz (Sustiva)FDA Link 04/2019
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2019
1	Peptide Hydrolases (Proteases)FDA Link 03/2018
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2018
1	bedaquiline (R207910)IBA 01/2018
1	FluoroquinolonesIBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Clofazimine (Lamprene)FDA Link 01/2018
1	Linezolid (Zyvox)FDA Link 01/2018
1	Hemoglobins (Hemoglobin)IBA 10/2017
1	Serum AlbuminIBA 10/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Fluconazole (Zonal)FDA LinkGeneric 06/2015
1	InterleukinsIBA 04/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2015
1	RifamycinsIBA 12/2012
1	prothrombin complex concentrates (PPSB)IBA 12/2012
1	Erythromycin (Erycette)FDA LinkGeneric 12/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2012
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 10/2012
1	Vitamin D FDA LinkGeneric 10/2012
1	Reverse Transcriptase InhibitorsIBA 05/2008
1	NucleosidesIBA 05/2008

Therapy/Procedure

20	Therapeutics 01/2021 - 01/2011
7	Art Therapy 12/2020 - 04/2013
2	Highly Active Antiretroviral Therapy (HAART) 06/2015 - 10/2008
1	Aftercare (After-Treatment) 01/2021
1	Duration of Therapy 01/2018
1	Glycemic Control 10/2012